Curevo Vaccine Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 44

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.5B

Curevo Vaccine General Information

Description

Developer of a clinical-stage adjuvanted subunit vaccine intended to improve efficacy and broaden immune response. The company leverages its proprietary platform to design and develop vaccines that target various infectious diseases, enabling healthcare professionals to create more effective and long-lasting immunizations.

Contact Information

Website
www.curevovaccine.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 18911 North Creek Parkway
  • Suite 150
  • Bothell, WA 98011
  • United States
+1 (206)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Lilly USA
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 18911 North Creek Parkway
  • Suite 150
  • Bothell, WA 98011
  • United States
+1 (206)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curevo Vaccine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 26-May-2026 $1.5B Completed Clinical Trials - Phase 2
5. Later Stage VC (Series B) 06-Mar-2025 Completed Clinical Trials - Phase 2
4. Mezzanine 30-Jun-2023 Completed Clinical Trials - Phase 2
3. Later Stage VC (Series A1) 16-Nov-2022 Completed Clinical Trials - Phase 1
2. Later Stage VC (Series A) 10-Feb-2022 $60M $60M Completed Startup
1. Joint Venture 01-Nov-2017 Completed Startup
To view Curevo Vaccine’s complete valuation and funding history, request access »

Curevo Vaccine Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a clinical-stage adjuvanted subunit vaccine intended to improve efficacy and broaden immune response. The c
Drug Discovery
Bothell, WA
44 As of 2026

San Diego, CA
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Curevo Vaccine Competitors (52)

One of Curevo Vaccine’s 52 competitors is Cidara Therapeutics, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cidara Therapeutics Formerly VC-backed San Diego, CA
Vir Biotechnology Formerly VC-backed San Francisco, CA
NGM Biopharmaceuticals Private Equity-Backed South San Francisco, CA
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 52 competitors. Get the full list »

Curevo Vaccine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curevo Vaccine Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Access to Advanced Health Institute Corporation Minority
Adjuvant Capital Impact Investing Minority
E&Investment Venture Capital Minority
EN Investment Venture Capital Minority
GC Biopharma Corporation Majority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Curevo Vaccine FAQs

  • When was Curevo Vaccine founded?

    Curevo Vaccine was founded in 2017.

  • Where is Curevo Vaccine headquartered?

    Curevo Vaccine is headquartered in Bothell, WA.

  • What is the size of Curevo Vaccine?

    Curevo Vaccine has 44 total employees.

  • What industry is Curevo Vaccine in?

    Curevo Vaccine’s primary industry is Drug Discovery.

  • Is Curevo Vaccine a private or public company?

    Curevo Vaccine is a Private company.

  • What is the current valuation of Curevo Vaccine?

    The current valuation of Curevo Vaccine is .

  • What is Curevo Vaccine’s current revenue?

    The current revenue for Curevo Vaccine is .

  • How much funding has Curevo Vaccine raised over time?

    Curevo Vaccine has raised $206M.

  • Who are Curevo Vaccine’s investors?

    Access to Advanced Health Institute, Adjuvant Capital, E&Investment, EN Investment, and GC Biopharma are 5 of 13 investors who have invested in Curevo Vaccine.

  • Who are Curevo Vaccine’s competitors?

    Cidara Therapeutics, Vir Biotechnology, NGM Biopharmaceuticals, Adaptimmune Therapeutics, and CytomX Therapeutics are some of the 52 competitors of Curevo Vaccine.

  • When was Curevo Vaccine acquired?

    Curevo Vaccine was acquired on 26-May-2026.

  • Who acquired Curevo Vaccine?

    Curevo Vaccine was acquired by Lilly USA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process